Kilitch Drugs (India) Limited (BOM:524500)

India · Delayed Price · Currency is INR

183.45

+6.25 (3.53%)

At close: Jul 27, 2026

Kilitch Drugs (India) Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	2,355	2,355	1,983	1,544	1,396	1,142
Revenue Growth	18.74%	18.74%	28.47%	10.58%	22.20%	66.71%
Gross Profit	1,093	1,093	930.05	749.8	641.83	468.49
Operating Income	329.77	329.77	291.97	222.98	148.56	100.16
Net Income	301.66	301.66	267.01	146.01	104.48	73.67
Earnings Per Share	8.91	8.91	8.30	4.58	3.35	2.36
EPS Growth	7.35%	7.35%	81.10%	36.71%	41.76%	99.58%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	862.49	706.43	567.76	413.34
Export	1,110	829.63	820.82	716.25
Unallocated	10.79	7.66	7.41	12.76
Total	1,983	1,544	1,396	1,142

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	687.39	687.39	593.66	690.71	591.77	572.96
Total Debt	887.09	887.09	494.24	316.47	221.94	204.32
Net Cash (Debt)	-199.7	-199.7	99.42	374.25	369.83	368.64
Net Cash Growth	-	-	-73.44%	1.19%	0.32%	8.11%
Net Cash Per Share	-5.90	-5.90	3.09	11.75	11.87	11.84

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	239.58	239.58	175.42	-15.35	25.86	57.83
Capital Expenditures	-995.07	-995.07	-468.73	-64.5	-38.12	-82.02
Free Cash Flow	-755.5	-755.5	-293.31	-79.85	-12.26	-24.19
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	46.43%	46.43%	46.90%	48.57%	45.98%	41.01%
Operating Margin	14.00%	14.00%	14.72%	14.44%	10.64%	8.77%
Pretax Margin	16.42%	16.42%	17.38%	12.54%	8.61%	8.42%
Profit Margin	12.81%	12.81%	13.46%	9.46%	7.48%	6.45%
FCF Margin	-32.08%	-32.08%	-14.79%	-5.17%	-0.88%	-2.12%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 28, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	20.59	14.78	21.77	42.94	20.81	35.47
PS Ratio	2.72	1.89	2.93	4.06	1.56	2.29